Yelena Bisharyan

Director of Business Development

Displaying: 1 - 10 of 20 Results

Red blood cell-hitchhiking to boost delivery of antivirals and immunotherapies to the lungs

Researchers in Samir Mitragotri’s lab have developed a way to traffic therapeutics directly to the lungs following routine intravenous injection and hope to apply the technology to treatment of acute respiratory distress syndrome (ARDS) and…

Investigators

  • Samir Mitragotri

Oral delivery of vaccines

Researchers in Samir Mitragotri’s lab have developed a platform technology that can deliver vaccines through oral administration. The technology features ionic liquids, salts that exist in the liquid phase at room temperature, that preserve protein…

Investigators

  • Samir Mitragotri

Ionic liquid aerosols for respiratory complications related to COVID-19

Researchers in the lab of Samir Mitragotri have developed ionic liquid aerosols that have the potential to combat pulmonary bacterial infections. The technology may help to treat the respiratory conditions resulting from COVID-19 infection and…

Investigators

  • Samir Mitragotri

Repurposing of therapeutics to block SARS-CoV-2 protease activity and pathogenesis

Researchers in Christina Woo’s lab are studying the essential mechanisms by which SARS-CoV-2 (novel coronavirus) co-opts normal cellular processes for viral replication. One mechanism that the team has identified indicates that the virus encodes…

Investigators

  • Christina Woo

Mutated IdsD proteins for treatment of Proteus mirabilis infections

Proteus mirabilis is part of the normal flora of the human gastrointestinal tract. It can also be found free living in water and soil. When this organism, however, enters the urinary tract, wounds, or the lungs it can become pathogenic. It commonly…

Investigators

  • Karine Gibbs

Universal Early Cancer Diagnostic

DescriptionThe methylation of DNA is an important epigenetic modification that regulates gene expression. A variety of disease states, cancer in particular, are thought to originate from defects in this process leading to changes in the DNA…

Investigators

  • Alexander Meissner

Oral delivery of biologics

Biologics are used to treat a variety of chronic diseases including diabetes and arthritis. Not surprisingly, they command a large share of the therapeutics market. Moreover, a large number of therapeutic proteins are currently in clinical…

Investigators

  • Samir Mitragotri

3D-brain organoids: Enabling discovery through patient-derived brain organoids

The Arlotta team is developing a 3D brain organoid platform, which makes it possible to study aspects of human brain development and neurodevelopmental disorders in a format amenable to large-scale production and genetic engineering.These organoids…

Investigators

  • Paola Arlotta
  • Giorgia Quadrato

FlicR: A bright and fast red fluorescent protein voltage indicator that reports neuronal activity

Fluorescent-protein-based voltage indicators enable imaging of the electrical activity of many genetically targeted neurons with high spatial and temporal resolution. FlicR is a new bright red fluorescent protein-based voltage indicator that has…

Investigators

  • Adam Ezra Cohen

Photostick: Physical isolation of single cells from tissue, for further propagation and single cell sequencing and omics

Photostick enables the physical selection of single cells from large populations in diverse environments. The novel process entails photochemical immobilization of live cells with patterned illumination, followed by removal of unwanted cells with…

Investigators

  • Adam Ezra Cohen
  • Miao-Ping Chien

Page 1 of 2